HLB, SPG, and Peptron have each surged more than 50% over the past month on the KOSDAQ, South Korea’s secondary stock exchange for small and mid-cap firms. This rally comes as the KOSPI, Korea’s main index, struggles to recover from a historic crash, falling 22% in July including a maximum decline of 34% from its July 22 record high. Regulators tightened rules on leveraged ETFs in early August, while a global AI-driven selloff hit chipmakers. HLB surged nearly 30% in a single day after FDA approval for a cancer drug. SPG is rising on its push into humanoid robot actuators, and Peptron is up on obesity drug supply chain speculation.
Source: Read the original article
